AZENTA INC (AZTA) Fundamental Analysis & Valuation

NASDAQ:AZTA • US1143401024

Current stock price

23.33 USD
+1.12 (+5.04%)
At close:
23.33 USD
0 (0%)
After Hours:

This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AZTA Profitability Analysis

1.1 Basic Checks

  • In the past year AZTA was profitable.
  • AZTA had a positive operating cash flow in the past year.
  • In multiple years AZTA reported negative net income over the last 5 years.
  • AZTA had a positive operating cash flow in 4 of the past 5 years.
AZTA Yearly Net Income VS EBIT VS OCF VS FCFAZTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • AZTA has a Return On Assets (-2.79%) which is in line with its industry peers.
  • AZTA has a better Return On Equity (-3.37%) than 61.40% of its industry peers.
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROIC N/A
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
AZTA Yearly ROA, ROE, ROICAZTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • The Gross Margin of AZTA (44.59%) is comparable to the rest of the industry.
  • AZTA's Gross Margin has been stable in the last couple of years.
  • AZTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
AZTA Yearly Profit, Operating, Gross MarginsAZTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

8

2. AZTA Health Analysis

2.1 Basic Checks

  • AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AZTA has been increased compared to 1 year ago.
  • AZTA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AZTA has an improved debt to assets ratio.
AZTA Yearly Shares OutstandingAZTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AZTA Yearly Total Debt VS Total AssetsAZTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • AZTA has an Altman-Z score of 3.21. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.21, AZTA is doing good in the industry, outperforming 70.18% of the companies in the same industry.
  • There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.21
ROIC/WACCN/A
WACC10.8%
AZTA Yearly LT Debt VS Equity VS FCFAZTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.92 indicates that AZTA has no problem at all paying its short term obligations.
  • AZTA's Current ratio of 2.92 is in line compared to the rest of the industry. AZTA outperforms 54.39% of its industry peers.
  • AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.61, AZTA perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.61
AZTA Yearly Current Assets VS Current LiabilitesAZTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. AZTA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.89% over the past year.
  • Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
  • Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
  • The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%

3.2 Future

  • Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
  • AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZTA Yearly Revenue VS EstimatesAZTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
AZTA Yearly EPS VS EstimatesAZTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. AZTA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 43.20, the valuation of AZTA can be described as expensive.
  • Based on the Price/Earnings ratio, AZTA is valued a bit cheaper than the industry average as 61.40% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (27.18), we can say AZTA is valued expensively.
  • Based on the Price/Forward Earnings ratio of 21.37, the valuation of AZTA can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 78.95% of the companies listed in the same industry.
  • AZTA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 43.2
Fwd PE 21.37
AZTA Price Earnings VS Forward Price EarningsAZTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 84.21% of the companies in the same industry are more expensive than AZTA, based on the Enterprise Value to EBITDA ratio.
  • AZTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.74
EV/EBITDA 13.54
AZTA Per share dataAZTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AZTA's earnings are expected to grow with 35.52% in the coming years.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y43.51%
EPS Next 3Y35.52%

0

5. AZTA Dividend Analysis

5.1 Amount

  • AZTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AZTA Fundamentals: All Metrics, Ratios and Statistics

AZENTA INC

NASDAQ:AZTA (4/13/2026, 8:09:58 PM)

After market: 23.33 0 (0%)

23.33

+1.12 (+5.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners116.07%
Inst Owner Change0.01%
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap1.07B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target37.74 (61.77%)
Short Float %10.54%
Short Ratio5.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-1.89%
PT rev (3m)-4.78%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-24.05%
EPS NY rev (1m)-0.71%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 43.2
Fwd PE 21.37
P/S 1.81
P/FCF 34.74
P/OCF 17.22
P/B 0.63
P/tB 1.17
EV/EBITDA 13.54
EPS(TTM)0.54
EY2.31%
EPS(NY)1.09
Fwd EY4.68%
FCF(TTM)0.67
FCFY2.88%
OCF(TTM)1.35
OCFY5.81%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.86
PEG (5Y)N/A
Graham Number21.27
Profitability
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.59%
FCFM 5.2%
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 55.45%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion 156.34%
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.61
Altman-Z 3.21
F-Score5
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year493.88%
EBIT Next 3Y107.95%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%

AZENTA INC / AZTA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AZENTA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AZTA.


What is the valuation status for AZTA stock?

ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.


Can you provide the profitability details for AZENTA INC?

AZENTA INC (AZTA) has a profitability rating of 3 / 10.


How financially healthy is AZENTA INC?

The financial health rating of AZENTA INC (AZTA) is 8 / 10.


What is the expected EPS growth for AZENTA INC (AZTA) stock?

The Earnings per Share (EPS) of AZENTA INC (AZTA) is expected to grow by 50.47% in the next year.